Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 8, 2026Archives of Women s Mental HealthOpen Access

Poor mood after oral contraceptive use is associated with increased vulnerability to peripartum depression, premenstrual dysphoric disorder, and higher genetic risk for depression

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJacqueline KiewaPLPenelope A. LindIHIan B. Hickie

Discussion

Loading...

Member takes

Overview

Randomized trial demonstrates that adverse mood effects from oral contraceptives increase risk for reproductive depressive episodes in women, indicating genetic vulnerability.

Key Points

  • This study aims to explore the relationship between mood effects of oral contraceptives and the risk of reproductive depression, focusing on PPD, PMDD, and genetic predisposition.
  • Logistic regression analyzed 3,547 OCP users from the Australian Genetics of Depression Study reporting lifetime depression diagnosis.
  • Examined associations between OCP mood effects and depressive episodes (PPD, PMDD, perimenopausal depression).
  • Polygenic scores for major depression assessed for correlation with adverse mood effects.
  • Participants with adverse mood effects from OCP use show a higher genetic vulnerability for depression (OR not provided).
  • Increased likelihood of experiencing child/teen depression onset in those reporting adverse mood effects (specific values not provided).
  • Higher incidence of reproductive depressive episodes like PPD and PMDD was observed in the adverse mood effect group (specific rates not provided).

Cite This Study

Kiewa et al. (2026) studied this question.

synapsesocial.com/papers/69fd7fa1bfa21ec5bbf08286https://doi.org/10.1007/s00737-026-01708-z
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association between combined oral contraceptive pills and depression in women with polyendocrine metabolic ovarian syndrome (formerly polycystic ovary syndrome): a comparative cross-sectional study2026
  2. 2HORMONAL CONTRACEPTION AND MOOD DISORDERS: CURRENT EVIDENCE ON DEPRESSION, ANXIETY AND EMOTIONAL WELL-BEING2026
  3. 3Assessing the association between combined oral contraceptive use, selected biomarkers, and depressive episodes among premenopausal women: a protocol for a systematic review and meta-analysis2026
  4. 4Genetic predisposition for depression, psychosocial and behavioural factors and premenstrual symptoms: a cross-sectional study among young women in China.2026
  5. 5The Influence of Hormonal Contraceptive Use on Psychiatric Health2025